The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJETG.L Regulatory News (JETG)

  • There is currently no data for JETG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

30 Nov 2017 15:41

RNS Number : 0326Y
JPMorgan European Invest Tst PLC
30 November 2017
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN EUROPEAN INVESTMENT TRUST PLC

UNAUDITED HALF YEAR RESULTS FOR THE SIX MONTHS ENDED30TH SEPTEMBER 2017

Legal Entity Identifier: 549300D8SPJFHBDGXS57

Information disclosed in accordance with the DTR 4.2.2

 

 

chairman's statement

Performance

In the six months to 30th September 2017 the returns to shareholders with net dividends reinvested in the Company's Growth (JETG) and Income (JETI) Portfolios were 9.0% and 11.9% respectively. Over the same period, the percentage increase in the Company's Growth and Income net asset value (NAV) were 10.4% and 9.7% respectively. Returns on both measures for the two portfolios were in excess of the benchmark. The Company's performance over one, three and five years was also positive.

The discount on the Growth share price to NAV widened during the reporting period, whereas the discount on the Income share price to NAV narrowed over the same period, reflecting the demand for income.

In their report on page 6 of the Half Year Report and Financial Statements, the Investment Managers comment on some of the factors underlying the performance of the two portfolios over the six month period, as well as commenting on the economic and market background.

Revenue and Dividends

The Board's aim is that annual dividend payments on the Growth shares continue to be broadly in line with revenues received on the underlying portfolio.

Revenue return per share on the Growth portfolio for the six months to 30th September 2017 (calculated by reference to the average number of shares in issue over the period) amounted to 6.27 pence per share (2016: 5.79 pence per share). A first interim dividend of 4.85 pence per Growth share was paid on 13th October 2017 (2016: 4.85 pence per share).

Revenue return per share on the Income portfolio for the half year (again, calculated by reference to the average number of shares in issue over the period) amounted to 4.59 pence per share (2016: 4.86 pence per share). The first quarterly interim dividend of 1.10 pence per Income share (2016: 1.10 pence per share) was paid on 23rd June 2017 and a second quarterly interim dividend also of 1.10 pence per Income share was paid on 13th October 2017 (2016: 1.10 pence per share). A third quarterly interim dividend of 1.10 pence per Income share (2016: 1.10 pence per share) was declared on 22nd November 2017 for payment on 12th January 2018. The Board's aim is to provide a regular stream of dividend income on a quarterly basis, subject to the availability of distributable reserves. The timing of the dividend declarations for the Growth second interim and Income fourth interim is expected to continue to be made ahead of the conversion opportunity in March each year.

Gearing

There has been no change in the Investment Manager's permitted gearing range, as previously set by the Board, of 10% net cash to 20% geared. At 30th September 2017 the Growth portfolio was 9.4% geared and the Income portfolio was 7.7% geared. These levels of gearing reflect a generally positive view on the outlook for stock market performance.

Conversions

The Company's next share conversion will be in March 2018 and details of the process will be posted on the Company's website in late January 2018.

Share Repurchases

The Board has a proactive approach to the use of its share repurchase powers. It remains of the view that it is important to seek to address imbalances in the supply of and demand for the Company's shares and to minimise thereby the volatility and absolute level of the discount to net asset value at which the Company's shares trade. The Board do not wish to see the discounts widen beyond 10% on an ongoing basis. The precise level and timing of repurchases pursuant to this policy depend upon prevailing market conditions. Over the six months under review the discount levels have averaged 9.5% for the Growth shares and 7.6% for the Income Shares (both at fair value). Over the six month period the Company repurchased a total of 30,116 Growth shares and no Income shares.

Transfer of Reserves between the Growth and Income Portfolios

Following shareholders' approval of the resolutions in the Company's Annual General Meeting (AGM) and Growth portfolio (JETG) and Income portfolio (JETI) Class Meetings on 17th July 2017, the Board now has the power to approve transfers of retained revenue reserves from JETG to JETI in exchange for the equivalent amount of capital reserves from JETI to JETG. Following the AGM during this reporting period, the Board exercised this power and £1.376m, being the amount of JETG's retained revenue reserve, after payment of the JETG 2.00p dividend paid on 7th April 2017, was transferred to JETI in exchange for the equivalent amount of capital reserves from JETI to JETG. This transfer is reflected in these Report and Financial Statements. Further explanation regarding the background to these transfers can be found in my Chairman's Statement in the Company's Annual Report and Financial Statements to 31st March 2017.

Outlook

Your Board remain optimistic about the outlook for European markets and believe that the Manager continues to position the Growth and Income portfolios to best achieve the Company's objectives for its shareholders.

 

For and on behalf of the Board

Andrew Adcock

Chairman

30th November 2017

 

 

Investment managers' report

Review

The period under review saw a further improvement in the Eurozone business environment with the recovery, which is now nearly four years old, continuing at a healthy pace, unemployment falling, consumer confidence rising, and business confidence improving everywhere. Bond yields rose modestly over the period, and the catalyst was more hawkish talk from central banks around the world, with the Fed sticking to their guns in talking of rate rises, and also revealing that plans were in train to think about how to shrink their balance sheet. In the Eurozone Mr Draghi said he was confident of continued recovery and the ECB felt emboldened to announce that they would taper their QE interventions, reducing their size from €60 billion to €30 billion a month.

The first and second quarter results season were a beat on earnings, and we initially saw continued upgrades to analyst estimates across a broad reach of sectors, until these were capped by Euro strength. European earnings are still expected to show healthy double-digit growth in 2017. The strength in PMIs and in demand suggests that the underlying direction of profitability is upwards, even if currency is a headwind.

The French election returned the moderate Mr Macron as President and he also gained a large majority in Parliament, removing both the threat of a populist President and the threat that Mr Macron would lack Parliamentary support for his reform programme. The German election returned Mrs Merkel's CDU/CSU as the largest party, though with a reduced majority, so talks to form a coalition are now in progress.

Income investing continued to outperform as a style, and this helped the Income share class, which targets a very high exposure to higher yielding stocks where the dividend is not under threat. In the Growth share class we continued to look for companies exposed to the strengthening cycle, and we also benefited from our holdings in higher quality banks.

Outlook

Confidence indicators remain positive in Europe, suggesting that the economy is growing above trend and has momentum. The ECB's tapering announcement is contributing to a modest steepening in Euro yield curves. This is consistent with an encouraging growth outlook and a rise in the cost of capital does not concern us unduly since we view any such rise as being modest and gradual.

If the steepening of yield curves continues we should see support for financials and cyclicals. Potential clouds on the horizon are a much weaker US Dollar, and further out the threat of the reversal of monetary accommodation by central banks (the Fed has announced specific plans to shrink its balance sheet). Markets have become used to easy money and plentiful liquidity and they will need time to become accustomed to a change, but as long as growth holds up and corporate profits are healthy we remain confident that equities can generate good returns.

 

Stephen Macklow-Smith

Alexander Fitzalan Howard

Michael Barakos

Thomas Buckingham

Investment Managers

30th November 2017

 

 

 

Interim Management Report

The Company is required to make the following disclosures in its half year report:

Principal Risks and Uncertainties

The principal risks and uncertainties faced by the Company fall into the following broad categories: investment and strategy; accounting, legal and regulatory; corporate governance and shareholder relations; operational; and financial. Information on each of these areas is given in the Business Review within the Annual Report and Accounts for the year ended 31st March 2017.

Related Parties Transactions

During the first six months of the current financial year, no transactions with related parties have taken place which have materially affected the financial position or the performance of the Company.

Going Concern

The Directors believe, having considered the Company's investment objectives, risk management policies, capital management policies and procedures, nature of the portfolio and expenditure projections, that the Company has adequate resources, an appropriate financial structure and suitable management arrangements in place to continue in operational existence for the foreseeable future and, more specifically, that there are no material uncertainties relating to the Company that would prevent its ability to continue in such operation existence for at least twelve months from the date of the approval of this half yearly financial report. For these reasons, they consider there is reasonable evidence to continue to adopt the going concern basis in preparing the accounts.

Directors' Responsibilities

The Board of Directors confirms that, to the best of its knowledge:

(i) the condensed set of financial statements contained within the half yearly financial report has been prepared in accordance with FRS 104 'Interim Financial Reporting' and gives a true and fair view of the state of affairs of the Company and of the assets, liabilities, financial position and net return of the Company, as at 30th September 2017, as required by the UK Listing Authority Disclosure and Transparency Rules 4.2.4R; and

(ii) the interim management report includes a fair review of the information required by 4.2.7R and 4.2.8R of the UK Listing Authority Disclosure and Transparency Rules.

In order to provide these confirmations, and in preparing these financial statements, the Directors are required to:

• select suitable accounting policies and then apply them consistently;

• make judgements and accounting estimates that are reasonable and prudent;

• state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business;

and the Directors confirm that they have done so.

For and on behalf of the Board

 

Andrew Adcock

Chairman

30th November 2017

 

 

 

statement of comprehensive income

for the six months ended 30th September 2017

(Unaudited)

Six months ended

30th September 2017

(Unaudited)

Six months ended

30th September 2016

(Audited)

Year ended

31st March 2017

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Gains on investments held at fair value through profit or loss

-

 34,880

 34,880

-

34,526

34,526

-

 79,794

 79,794

Net foreign currency losses

-

(1,683)

(1,683)

-

(241)

(241)

-

 (51)

 (51)

Income from investments

 11,431

-

 11,431

10,739

-

10,739

 14,833

-

 14,833

Interest receivable and similar income

 32

-

 32

75

-

75

103

-

103

Gross return

 11,463

33,197

44,660

10,814

34,285

45,099

 14,936

79,743

94,679

Management fee

 (597)

(1,157)

(1,754)

(482)

(936)

(1,418)

 (1,018)

(1,976)

(2,994)

Other administrative expenses

 (362)

-

 (362)

(416)

-

(416)

 (814)

-

 (814)

Net return on ordinary activities before finance costs and taxation

 10,504

 32,040

 42,544

9,916

33,349

43,265

 13,104

 77,767

 90,871

Finance costs

(239)

(474)

(713)

(234)

(460)

(694)

 (456)

(896)

(1,352)

Net return on ordinary activities before taxation

 10,265

 31,566

 41,831

9,682

32,889

42,571

 12,648

 76,871

 89,519

Taxation

 (1,121)

-

(1,121)

(618)

-

(618)

(1,833)

-

(1,833)

Net return on ordinary activities after taxation

 9,144

 31,566

 40,710

9,064

32,889

41,953

 10,815

 76,871

 87,686

Return per share (note 3):

Growth share

6.27p

26.85p

33.12p

5.79p

27.46p

33.25p

6.75p

61.08p

67.83p

Income share

4.59p

11.56p

16.15p

4.86p

12.31p

17.17p

5.94p

31.40p

37.34p

 

 

 

 

Statement of ChangeS in Equity

for the six months ended 30th September 2017

Called up

Capital

share

Share

redemption

Capital

Revenue

capital

premium

reserve

reserves1

reserve1

Total

£'000

£'000

£'000

£'000

£'000

£'000

Six months ended 30th September 2017 (Unaudited)

At 31st March 2017

5,024

84,114

14,864

298,082

5,871

407,955

Repurchase and cancellation of the Company's own shares

 (1)

-

 1

 (91)

-

 (91)

Net return on ordinary activities

-

-

-

 31,566

 9,144

 40,710

Dividends paid in the period (note 4)

-

-

-

-

 (4,173)

 (4,173)

At 30th September 2017

 5,023

 84,114

 14,865

 329,557

 10,842

444,401

Six months ended 30th September 2016 (Unaudited)

At 31st March 2016

6,279

82,761

13,591

224,306

3,930

330,867

Repurchase and cancellation of the Company's own shares

 (9)

-

 9

 (435)

-

 (435)

Net return on ordinary activities

-

-

-

32,889

9,064

41,953

Dividends paid in the period (note 4)

-

-

-

-

(3,041)

(3,041)

At 30th September 2016

6,270

82,761

13,600

256,760

9,953

369,344

Year ended 31st March 2017 (Audited)

At 31st March 2016

6,279

82,761

13,591

224,306

3,930

330,867

Repurchase and cancellation of the Company's own shares

(34)

-

34

(1,724)

-

(1,724)

Share conversions during the year

-

1,353

18

(1,371)

-

-

Adjustment on repurchase of deferred shares issued arising from share conversion

(1,221)

-

1,221

-

-

-

Net return on ordinary activities

-

-

-

76,871

10,815

87,686

Dividends paid in the year (note 4)

-

-

-

-

(8,874)

(8,874)

At 31st March 2017

5,024

84,114

14,864

298,082

5,871

407,955

1 These reserves form the distributable reserves of the Company and may be used to fund distribution of profits to investors via dividend payments.

 

 

 

Statement of Financial Position

at 30th September 2017

(Unaudited)

30th September 2017

(Unaudited)

30th September

2016

(Audited)

31st March

2017

Growth

Income

Total

Total

Total

£'000

£'000

£'000

£'000

£'000

Fixed assets

Investments held at fair value through profit or loss

 298,260

 185,125

 483,385

 369,345

435,814

Current assets

Derivative financial assets

 54

 323

 377

 150

394

Debtors

 755

 588

 1,343

 1,761

1,810

Cash and cash equivalents

 9,141

 8,355

 17,496

 55,460

25,920

 9,950

 9,266

 19,216

 57,371

28,124

Current liabilities

Creditors: amounts falling due within one year

 (8,837)

 (5,442)

 (14,279)

 (14,011)

(13,421)

Derivative financial liabilities

 (43)

 (44)

 (87)

 (337)

(18)

Net current assets

 1,070

 3,780

 4,850

 43,023

14,685

Total assets less current liabilities

 299,330

 188,905

 488,235

 412,368

450,499

Creditors: amounts falling due after more than one year

 (26,803)

 (17,031)

 (43,834)

 (43,024)

(42,544)

Net assets

272,527

171,874

 444,401

 369,344

407,955

Capital and reserves

Called up share capital

 3,065

 1,958

 5,023

 6,270

5,024

Share premium reserve

 11,448

 72,666

 84,114

 82,761

84,114

Capital redemption reserve

 13,500

 1,365

 14,865

 13,600

14,864

Capital reserves

 239,674

 89,883

 329,557

 256,760

298,082

Revenue reserve

 4,840

 6,002

 10,842

 9,953

5,871

Total shareholders' funds

272,527

171,874

 444,401

369,344

407,955

Net asset values (note 5):

Net asset value per Growth share

353.1p

292.0p

321.9p

Net asset value per Income share

183.3p

151.9p

169.9p

 

 

 

Statement of Cash flows

for the six months ended 30th September 2017

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

30th September

30th September

31st March

2017

2016

2017

£'000

£'000

£'000

Net cash (outflow)/inflow from operations before dividends and interest

 (1,609)

 2,508

 222

Dividends received

 10,759

 9,368

 11,612

Interest received

-

 2

 2

Overseas tax recovered

 113

 167

 524

Net cash inflow from operating activities

 9,263

 12,045

 12,360

Purchases of investments and derivatives

 (140,132)

 (116,898)

 (289,356)

Sales of investments and derivatives

 128,336

 146,595

 297,400

Settlement of future contracts

 (291)

 1,089

 1,014

Settlement of foreign currency contracts

 (409)

 (292)

 (384)

Net cash (outflow)/inflow from investing activities

 (12,496)

 30,494

 8,674

Dividends paid

 (4,173)

 (3,041)

 (8,874)

Repurchase and cancellation of the Company's own shares

 (354)

 (435)

 (1,461)

Interest paid

 (663)

 (682)

 (1,327)

Net cash outflow from financing activities

 (5,190)

 (4,158)

 (11,662)

(Decrease)/Increase in cash and cash equivalents

 (8,423)

 38,381

 9,372

Cash and cash equivalents at start of period/year

 25,920

 16,583

 16,583

Exchange movements

 (1)

 496

 (35)

Cash and cash equivalents at end of period/year

 17,496

 55,460

 25,920

(Decrease)/Increase in cash and cash equivalents

 (8,423)

 38,381

 9,372

Cash and cash equivalents consist of:

Cash and short term deposits

 681

 31,658

 5,953

JPMorgan Euro Liquidity Fund

 16,815

 23,802

 19,967

Total

 17,496

 55,460

 25,920

 

 

Notes to the financial statements for the six months ended 30th September 2017

1. Financial statements

The information contained within the financial statements in this half year report has not been audited or reviewed by the Company's auditors.

The figures and financial information for the year ended 31st March 2017 are extracted from the latest published financial statements of the Company and do not constitute statutory accounts for that year. Those financial statements have been delivered to the Registrar of Companies and including the report of the auditors which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.

2. Accounting policies

The financial statements have been prepared in accordance with the Companies Act 2006, FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' of the United Kingdom Generally Accepted Accounting Practice ('UK GAAP') and with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (the revised 'SORP') issued by the Association of Investment Companies in November 2014 and updated in January 2017.

FRS 104, 'Interim Financial Reporting', issued by the Financial Reporting Council ('FRC') in March 2015 has been applied in preparing this condensed set of financial statements for the six months ended 30th September 2017.

All of the Company's operations are of a continuing nature.

The accounting policies applied to this condensed set of financial statements are consistent with those applied in the financial statements for the year ended 31st March 2017.

3. Return per share

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

30th September

30th September

31st March

 2017

2016

2017

Growth Share

£'000

£'000

£'000

Return per share is based on the following:

Revenue return

4,840

4,497

5,242

Capital return

20,726

21,336

47,403

Total return

25,566

25,833

52,645

Weighted average number of shares in issue

77,196,087

77,709,134

77,612,534

Revenue return per share

6.27p

5.79p

6.75p

Capital return per share

26.85p

27.46p

61.08p

Total return per share

33.12p

33.25p

67.83p

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

30th September

30th September

31st March

 2017

2016

2017

Income Share

£'000

£'000

£'000

Return per share is based on the following:

Revenue return

4,304

4,567

5,573

Capital return

10,840

11,553

29,468

Total return

15,144

16,120

35,041

Weighted average number of shares in issue

93,769,494

93,884,791

93,837,413

Revenue return per share

4.59p

4.86p

5.94p

Capital return per share

11.56p

12.31p

31.40p

Total return per share

16.15p

17.17p

37.34p

 

4. Dividends

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

30th September

30th September

31st March

 2017

2016

2017

£'000

£'000

£'000

Dividends paid

Unclaimed Growth dividends refunded to the Company

-

(2)

(2)

Growth 2017 second interim dividend of 2.00p (2016: 1.00p)

1,549

852

852

Growth 2017 first interim dividend of 4.85p (2016: 4.85p)

-

-

3,767

Income 2017 fourth interim dividend of 1.70p (2016 second interim: 1.45p)

1,593

1,158

1,158

Income 2018 first interim dividend of 1.10p (2017: 1.10p)

1,031

1,033

1,033

Income 2017 second interim dividend of 1.10p

-

-

1,033

Income 2017 third interim dividend of 1.10p

-

-

1,033

Total dividends paid in the period

4,173

3,041

8,874

 

 

 

Dividends declared

Growth 2017 second interim dividend of 2.00p

-

-

1,549

Growth 2018 first interim dividend of 4.85p (2017: 4.85p)

3,744

3,766

-

Income 2017 fourth interim dividend of 1.70p

-

-

1,593

Income 2018 second interim dividend of 1.10p (2017: 1.10p)

1,031

1,033

-

Income 2018 third interim dividend of 1.10p (2017: 1.10p)

1,031

1,033

-

Total dividends declared

5,806

5,832

3,142

All dividends paid and declared in the period have been funded from the Revenue Reserve.

5. Net asset value per share

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

30th September

30th September

31st March

 2017

2016

2017

Growth Share

Net assets (£'000)

272,527

226,713

248,601

Number of shares in issue

77,190,492

77,652,655

77,220,608

Net asset value per share

353.1p

292.0p

321.9p

Income Share

Net assets (£'000)

171,874

142,631

159,354

Number of shares in issue

93,769,494

93,884,791

93,769,494

Net asset value per share

183.3p

151.9p

169.9p

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

30 November 2017

For further information, please contact:

Paul Winship

For and on behalf of

JPMorgan Funds Limited, Secretary

020 7742 4000

 

JPMORGAN FUNDS LIMITED

ENDS

A copy of the half year will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.hemscott.com/nsm.do

The half year will also shortly be available on the Company's website at www.jpmeuropean.co.uk where up to date information on the Company, including daily NAV and share prices, factsheets and portfolio information can also be found.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BUBDBLXXBGRG
Date   Source Headline
3rd Feb 20226:00 pmRNSJPMorgan European Investment Trust
3rd Feb 20222:57 pmRNSResults of Restructuring and Amendments to Listing
1st Feb 202211:25 amRNSNet Asset Value(s)
1st Feb 20229:19 amRNSTotal Voting Rights
31st Jan 202212:13 pmRNSGearing Announcement
31st Jan 202211:54 amRNSNet Asset Value(s)
28th Jan 202211:49 amRNSNet Asset Value(s)
27th Jan 202211:20 amRNSNet Asset Value(s)
26th Jan 202212:01 pmRNSNet Asset Value(s)
25th Jan 202211:58 amRNSNet Asset Value(s)
24th Jan 20221:52 pmRNSGearing Announcement
24th Jan 20221:01 pmRNSNet Asset Value(s)
24th Jan 202212:35 pmRNSResults of Meetings and Transaction Update
21st Jan 202212:28 pmRNSNet Asset Value(s)
20th Jan 202212:12 pmRNSNet Asset Value(s)
19th Jan 202211:45 amRNSNet Asset Value(s)
18th Jan 202211:06 amRNSNet Asset Value(s)
17th Jan 20224:59 pmRNSTransaction in Own Shares
17th Jan 202212:42 pmRNSTen Largest Investments
17th Jan 202211:51 amRNSGearing Announcement
17th Jan 202211:45 amRNSNet Asset Value(s)
14th Jan 202211:17 amRNSNet Asset Value(s)
13th Jan 202210:52 amRNSNet Asset Value(s)
12th Jan 20225:27 pmRNSTransaction in Own Shares
12th Jan 202210:39 amRNSNet Asset Value(s)
11th Jan 202210:58 amRNSNet Asset Value(s)
10th Jan 202211:46 amRNSGearing Announcement
10th Jan 202211:07 amRNSNet Asset Value(s)
7th Jan 202211:02 amRNSNet Asset Value(s)
6th Jan 202211:12 amRNSNet Asset Value(s)
5th Jan 202211:14 amRNSNet Asset Value(s)
4th Jan 20222:56 pmRNSTotal Voting Rights
4th Jan 20221:21 pmRNSGearing Announcement
4th Jan 20221:18 pmRNSNet Asset Value(s)
31st Dec 202111:46 amRNSNet Asset Value(s)
30th Dec 202111:04 amRNSNet Asset Value(s)
29th Dec 20215:21 pmRNSTransaction in Own Shares
29th Dec 202112:14 pmRNSGearing Announcement
29th Dec 202111:16 amRNSNet Asset Value(s)
24th Dec 202111:31 amRNSNet Asset Value(s)
23rd Dec 202110:44 amRNSNet Asset Value(s)
22nd Dec 202110:43 amRNSNet Asset Value(s)
22nd Dec 202110:13 amRNSDirectorate Change
21st Dec 202111:20 amRNSNet Asset Value(s)
20th Dec 20214:34 pmRNSPublication of Circular
20th Dec 202111:18 amRNSNet Asset Value(s)
20th Dec 202110:54 amRNSGearing Announcement
17th Dec 202111:27 amRNSNet Asset Value(s)
16th Dec 202111:09 amRNSNet Asset Value(s)
15th Dec 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.